Janus Henderson Group
TRDA icon

Janus Henderson Group’s Entrada Therapeutics TRDA Stock Holding History

Janus Henderson Group’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,521,281
Closed -$10.2M – 2472
2025
Q2 		$10.2M Sell
1,521,281
-600,373
-28% -$4.83M 0.01% 717
2025
Q1 		$20.3M Buy
2,121,654
+41,287
+2% +$514K 0.01% 570
2024
Q4 		$36M Buy
2,080,367
+368,908
+22% +$6.68M 0.02% 450
2024
Q3 		$27.4M Buy
1,711,459
+161,962
+10% +$2.55M 0.01% 511
2024
Q2 		$22.1M Buy
+1,549,497
New +$22M 0.01% 542

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
CF
Cantor Fitzgerald New York $2.76B AUM 29.01% 1-Year Est. Return